{"title":"1例前列腺癌多发骨转移患者经化疗联合内分泌治疗6年后完全缓解。","authors":"Zhicheng Lu, Jian Sun, Ke Xu","doi":"10.1159/000545854","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Prostate cancer is one of the most common malignant tumors in men, and bone metastasis is a common complication that severely affects patients' quality of life and survival rates.</p><p><strong>Case presentation: </strong>This article reports a case of a patient with multiple bone metastases from prostate cancer who achieved complete remission and survived for 6 years following chemotherapy combined with endocrine therapy.</p><p><strong>Conclusion: </strong>By detailing the patient's treatment process and follow-up results, the article explores the application value of chemotherapy combined with endocrine therapy in the management of bone metastases in prostate cancer.</p>","PeriodicalId":9625,"journal":{"name":"Case Reports in Oncology","volume":"18 1","pages":"836-844"},"PeriodicalIF":0.7000,"publicationDate":"2025-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12201939/pdf/","citationCount":"0","resultStr":"{\"title\":\"A Case Report of a Patient with Multiple Bone Metastases from Prostate Cancer Achieving Complete Remission for 6 Years after Chemotherapy Combined with Endocrine Therapy.\",\"authors\":\"Zhicheng Lu, Jian Sun, Ke Xu\",\"doi\":\"10.1159/000545854\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Prostate cancer is one of the most common malignant tumors in men, and bone metastasis is a common complication that severely affects patients' quality of life and survival rates.</p><p><strong>Case presentation: </strong>This article reports a case of a patient with multiple bone metastases from prostate cancer who achieved complete remission and survived for 6 years following chemotherapy combined with endocrine therapy.</p><p><strong>Conclusion: </strong>By detailing the patient's treatment process and follow-up results, the article explores the application value of chemotherapy combined with endocrine therapy in the management of bone metastases in prostate cancer.</p>\",\"PeriodicalId\":9625,\"journal\":{\"name\":\"Case Reports in Oncology\",\"volume\":\"18 1\",\"pages\":\"836-844\"},\"PeriodicalIF\":0.7000,\"publicationDate\":\"2025-05-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12201939/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Case Reports in Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1159/000545854\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000545854","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
A Case Report of a Patient with Multiple Bone Metastases from Prostate Cancer Achieving Complete Remission for 6 Years after Chemotherapy Combined with Endocrine Therapy.
Introduction: Prostate cancer is one of the most common malignant tumors in men, and bone metastasis is a common complication that severely affects patients' quality of life and survival rates.
Case presentation: This article reports a case of a patient with multiple bone metastases from prostate cancer who achieved complete remission and survived for 6 years following chemotherapy combined with endocrine therapy.
Conclusion: By detailing the patient's treatment process and follow-up results, the article explores the application value of chemotherapy combined with endocrine therapy in the management of bone metastases in prostate cancer.